Martin J. Edelman, MD, FACP, FASCO

Chair, Department of Hematology/Oncology

Dr. Edelman collaborates with our clinical, scientific, and administrative leadership to grow robust therapeutic, clinical research, and translational research programs in hematology and medical oncology while leading the department in evaluating emerging national trends in the delivery of care to cancer patients. Dr. Edelman is the inaugural Chair of the Department of Lewis Katz School of Medicine. In addition, Dr. Edelman is Associate Cancer Center Director for Clinical Research Integration, responsible for developing the clinical research program throughout the Temple University Health System.

A nationally recognized expert in the treatment and research of lung cancer, Dr. Edelman developed one of the most commonly used regimens for treating advanced lung cancer and has focused on the development of new agents and biomarkers to personalize lung cancer therapy. He has a particular interest in approaches that integrate surgery, radiation, and chemotherapy in the management of lung cancer patients. His research has been supported by grants and contracts from the NCI, DOD and industry.

Dr. Edelman serves on the Thoracic Malignancies Steering Committee of the National Cancer Institute’s Scientific Review Group. He has been an active member of the National Clinical Trials Network for over 35 years and is the Medical Oncology Co-chair for the Lung Cancer Committee of the Radiation Therapy Oncology Group (RTOG, NRG). He is an active member and past chair of the Career Development and Ethics Committee and currently a member of the Communications Committee of the International Association for the Study of Lung Cancer (IASLC). He is a member of the Small Cell committee of the NCCN and the Executive Committee of the American Radium Society.

Dr. Edelman has published more than 325 scientific articles, abstracts, and book chapters. In addition, he has served on the editorial boards or as an ad-hoc reviewer of numerous academic journals and currently serves as Deputy Editor of the journal Lung Cancer.